drugset / Trial / NCT06663254

Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery

NCT06663254

Phase 4 Not yet recruiting 410 enrolled Xiangya Hospital of Central South University
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators propose a multicenter randomized trial to test the renal safety of 6% hydroxyethyl starch (HES) 130/0.4 combined with sodium acetate Ringer's crystalloid solution in moderate-to-high cardiovascular risk patients having major abdominal surgery. The reference group will only be given sodium acetate Ringer's crystalloid.

Timeline

Start
2024-11-30
Primary completion
2026-03-30
Completion
2026-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Volulyte Other / unclassified 200 ml
Background Sodium acetate Ringer Unknown

Indications

No indication recorded.